Alzheimer’s Protein and Its Dual Role in Immunity and Cancer

In a new study published in the journal Cancer Research, researchers have discovered that a protein strongly associated with Alzheimer’s disease can also enhance the immune system’s strength. This finding could pave the way for new approaches to treating cancer, neurodegenerative disorders, and age-related decline.

Alzheimer’s and Cancer: A Scientific Paradox

For many years, researchers have noticed something peculiar in population data: individuals diagnosed with Alzheimer’s disease appear to be less likely to develop cancer. This unusual pattern intrigued Dr. Besim Ogretmen and his team, prompting them to explore the biological explanation behind it.

Epidemiologist Dr. Kalyani Sonawan led the effort to verify this link, examining national survey data over five years. Her team found clear evidence that adults over the age of 59 with Alzheimer’s were 21 times less likely to develop cancer compared to those without the disease.

Biological Exchange

Through a series of experiments, researchers traced the connection to a familiar protein: beta-amyloid, known for forming harmful plaques in the brains of Alzheimer’s patients. They discovered that this protein has two contrasting roles depending on its location. In the brain, it causes neuronal damage, while in the immune system, it seems to bolster immune cells.

Beta-amyloid interferes with a cellular recycling process known as mitophagy, which normally removes damaged mitochondria. In the brain, blocking this process leads to the accumulation of faulty mitochondria, releasing toxins and causing neuronal cell death, which exacerbates memory loss and cognitive decline.

Immune System Rejuvenation

To explore this further, the team transplanted mitochondria from T cells of Alzheimer’s patients into aging T cells from individuals without the disease. The result was remarkable, as the old cells began functioning like young, active ones again.

The findings also showed that beta-amyloid contributes to cancer in another way—by depleting fumarate, a small molecule produced within mitochondria during energy production. Fumarate acts as a brake, keeping mitophagy from spiraling out of control.

Broad Implications for Cancer and Aging

These discoveries highlight why individuals with Alzheimer’s are less prone to cancer and how this protection might be harnessed. Instead of directly attacking tumors, this research suggests a new generation of treatments that recharge the immune system itself.

These strategies could be widely applied in cancer treatment. Revitalizing T cells through healthy mitochondrial transplantation could enhance current therapies like CAR-T cell therapy. Fumarate-based drugs or supplements might extend the lifespan and vitality of older immune cells by preserving their mitochondria.

Conclusion

In conclusion, these findings illustrate how a protein associated with Alzheimer’s can have a dual impact, offering new opportunities in cancer and aging treatment. Through collaboration among researchers from different fields, these discoveries could open unexpected doors to a deeper understanding of the relationship between neurodegenerative diseases and future immunotherapies.